epa08600537 A handout photo made available by the Russian Direct Investment Fund (RDIF) shows containers with a new two-vector COVID-19 vaccine at Nikolai Gamaleya National Center of Epidemiology and Microbiology in Moscow, Russia, 06 August 2020 (issued 13 August 2020). Russia registered the new called Sputnik V vaccine against coronavirus Sars-Cov-2 and opens the stage of its massive testing. EPA/RDIF HANDOUT NO RESTRICTIONS, ALLOW TO USE IN SOCIAL NETWORK HANDOUT EDITORIAL USE ONLY/NO SALES